UnitedHealth price target lowered to $572 from $592 at RBC Capital

RBC Capital analyst Ben Hendrix lowered the firm’s price target on UnitedHealth to $572 from $592 and keeps an Outperform rating on the shares. Second quarter medical cost trend played out as advertised in mid-June with elevated utilization primarily reflecting outpatient electives within the MA book, while commercial and Medicaid appear to be tracking to expectations, aside from elevated behavioral volume, the analyst tells investors in a research note.